Commentary

Podcast

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP ,Aislinn Antrim, Managing Editor

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial and the newest ACS guidelines.

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.

For more information:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Warning sign surrounded by pills | Image Credit: © Vadym - stock.adobe.com
Network | Image Credit: © Georgy - stock.adobe.com
Medical team | Image Credit: © Jacob Lund - stock.adobe.com
Pharmacist inspecting medication. | Image Credit: © Inna - stock.adobe.com.
Pharmacist accessing EMR | Image credit: @ Justlight - stock.adobe.com
Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service - Image credit: Chinnapong | stock.adobe.com
Related Content
Blood cancer cells | Image Credit: © stock_acc - stock.adobe.com
August 5th 2025

Discontinuing Lenalidomide After ASCT May Be Safe for Select MRD-Negative Patients With Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 5th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Hyperlipidemia or arteriosclerosis. Blocked artery concept and human blood vessel as a disease with cholesterol fat buildup clogging. Clogged arteries, Cholesterol plaque in the artery. 3D Rendering - Image credit: Superrider | stock.adobe.com
August 5th 2025

Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia

Kennedy Ferruggia, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 5th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Updated European MASLD Guidelines Review Prevention, Screening, and Treatments
August 5th 2025

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Huiqiao (Melinda) Fan, BSc
Twice-Yearly Inclisiran Boosts LDL-C Control Post-MI in V-INCEPTION Trial
August 5th 2025

Twice-Yearly Inclisiran Boosts LDL-C Control Post-MI in V-INCEPTION Trial

Kirk Knowlton, MD Alana Hippensteele, Lead Editor